Anti-Fibrinolytic Agents In Traumatic Haemorrhage

Journal Title: Journal of Neurological Sciences-Turkish - Year 2005, Vol 22, Issue 2

Abstract

For people at ages 5 to 45 years, trauma is second only to HIV/AIDS as a cause of death. Each year, worldwide, over three million people die as a result of trauma, many after reaching hospital. Among trauma patients who do survive to reach hospital, exsanguination is a common cause of death, accounting for nearly half of in-hospital trauma deaths. Central nervous system injury and multi-organ failure account for most of the remainder, both of which can be exacerbated by severe bleeding. Systemic anti-fibrinolytic agents are widely used in major surgery to prevent fibrinolysis and thus reduce surgical blood loss. A recent systematic review6 of randomised controlled trials of anti-fibrinolytic agents (mainly aprotinin or tranexamic acid) in elective surgical patients identified 89 trials including 8,580 randomised patients (74 trials in cardiac, eight in orthopaedic, four in liver, and three in vascular surgery). The results showed that these treatments reduced the numbers needing transfusion by one third, reduced the volume needed per transfusion by one unit, and halved the need for further surgery to control bleeding. These differences were all highly statistically significant. There was also a statistically non-significant reduction in the risk of death (RR=0.85: 95%CI 0.63 to 1.14) in the anti-fibrinolytic treated group. The CRASH 2 trial will be a large international, placebo controlled trial of the effects of the early administration of the anti-fibrinolytic agent tranexamic acid on death, vascular events and transfusion requirements.

Authors and Affiliations

Lan ROBERTS, Tim COATS, Hunt BEVERLY, Shakur HALEEMA

Keywords

Related Articles

Succinic Semialdehyde Dehydrogenase Deficiency : Three Sibling in A Family (Case Report)

Succinic semialdehyde dehydrogenase enzyme (SSADH) deficiency is a rare autosomal disorder involving the catabolism of the neurotransmitter γ-amino butyric acid (GABA). In the absence of SSADH, GABA is converted to 4-hyd...

The Role Of Acute Phase Reactants In Acute Ischemic Stroke

Inflammatory factors play an important role in the pathogenesis of ischemic stroke. The aim of our study was to determine the influence of fibrinogen, C-reactive protein and other acute-phase reactant levels in acute isc...

Spinal cord mature cystic teratoma

Spinal cord teratoma is very rare lesion. Intradural spinal teratoma consists of 0,1% of all spinal tumours. Teratomas are classified into three groups: mature, immature and malignant teratomas. The authors report a 12 y...

The Role of Thrombocyte Activation on Early Brain Injury in Experimental Subarachnoid Hemorrhage Model

Aim: Thrombocyte activation is one of the mechanisms blamed for emerging of early brain injury(EBI) soon after subarachnoid hemorrhage(SAH). It is wondered by researching to what extend neuron injury is prevented by maki...

Paget’s Disease Of The Spine With Low Bone Alkaline Phosphatase

We present a case of 35-year-old man who was referred to us with a preliminary diagnosis of multiple spinal metastasis. Laboratory studies have shown a high serum alkaline phosphatase and a low bone alkaline phosphatase...

Download PDF file
  • EP ID EP118521
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

Lan ROBERTS, Tim COATS, Hunt BEVERLY, Shakur HALEEMA (2005). Anti-Fibrinolytic Agents In Traumatic Haemorrhage. Journal of Neurological Sciences-Turkish, 22(2), 231-234. https://europub.co.uk/articles/-A-118521